The second International Forum of Pharmaceutical Inspectorates (IFPI) was held in Abu Dhabi, bringing together regulators and executives from leading pharmaceutical companies across more than 50 countries.
For the second consecutive year, the Russian Federation co-chaired the Forum’s Organizing Committee, underscoring its leading role in global regulatory harmonization processes.
The Forum provided a platform for constructive market interaction, the exchange of international best practices, and improving drug quality control mechanisms. The primary focus was on challenges in certifying production facilities to international GMP standards. The event became a pivotal gathering for advancing global harmonization approaches in GMP regulation, serving as a venue for aligning strategies, sharing best practices in Good Manufacturing Practice oversight, and addressing emerging issues in the pharmaceutical supply chain.
Key forum topics also included the mutual recognition of GMP certificates by different states, including the EAEU certificate, and optimizing procedures for registering new drugs.
Representatives from the Eurasian Academy of Good Practices (EAGP) held a master class on VR technologies for training GMP specialists for all forum participants. The Academy’s “VR Plant” project is already widely used for training staff at pharmaceutical enterprises, notably at the plant of R-Pharma. R-Pharma’s project “Virtual Technologies as a Tool for Upskilling Pharmaceutical Enterprise Employees” was entered into the international “GxP-Profi” competition and received positive feedback from the professional jury.
The participation of the Russian Ministry of Industry and Trade alongside the State Institute of Medicines and Good Practices at the International Forum is a significant step toward deeper integration of Russia into the global GMP community and confirms its commitment to aligning Russian production standards with international practices.
The delegation from Soteх held several bilateral meetings and participated in a roundtable with regulatory authorities, discussing the requirements of participating countries for obtaining GMP certificates and presenting the company’s product line. The participation resulted in an agreement to continue active cooperation with responsible officials from relevant agencies regarding GMP inspections and potential drug registration in their respective territories.
“Soteх’s participation in the International Forum aims to expand its presence in global markets and strengthen international trust in its production processes and product quality,” a company representative told the editorial board. “The event played a key role in the development of the global pharmaceutical sector and strengthened cooperation between national regulatory bodies.”
